<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Valeant Pharmaceuticals International | Company News & Executive Profiles - VRX | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Valeant Pharmaceuticals International]]></description>
	<s:counts start="0" returned="10" found="14" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Valeant Pharmaceuticals International Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-359587.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Your first question comes from Gary Nachman &#8211; Leerink Swann. Gary Nachman &#8211; Leerink Swann First question, I guess, to Peter, how were you able to recognize so much profit sharing from generic BenzaClin?  That deal closed at the end of September.  And is...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 02 Nov 2009 11:12:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/quarter.html"><![CDATA[Quarter]]></category>
		<category domain="http://resources.bnet.com/topic/the+dow+chemical+co..html"><![CDATA[The Dow Chemical Co.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html"><![CDATA[Valeant Pharmaceuticals International]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DOW</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
		<category domain="tickers">DOW,VRX</category>
	</item>
	<item>
		<title><![CDATA[Valeant: It Turns Out that Wrinkles Are Worth Quite a Lot]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F170563-valeant-it-turns-out-that-wrinkles-are-worth-quite-a-lot%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Carol Flake Chapman submits: I wrote about Valeant Pharmaceuticals VRX back on June 16, when the stock was trading at a little over $22. The company came to my notice because of Efudex, its treatment for actinic keratosis and basal cell carcinoma. Not only does the treatment work to remedy...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 02 Nov 2009 08:01:43 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/carol+flake+chapman.html"><![CDATA[Carol Flake Chapman]]></category>
		<category domain="http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html"><![CDATA[Valeant Pharmaceuticals International]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
		<category domain="tickers">VRX</category>
	</item>
	<item>
		<title><![CDATA[Valeant's Six New Value Aligned Pay Practices]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F159828-valeant-s-six-new-value-aligned-pay-practices%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Value Expectations submits:  By David Lee Berkowitz     Valeant CEO's Pay Package Draws Praise as a Model - WSJ.com.   In the above article in Wednesday's WSJ, G Mason Morfit, chairman of Valeant's VRX board compensation committee and a partner at ValueAct, an activist hedge...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 03 Sep 2009 07:16:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/value+expectations.html"><![CDATA[Value Expectations]]></category>
		<category domain="http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html"><![CDATA[Valeant Pharmaceuticals International]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
		<category domain="tickers">VRX</category>
	</item>
	<item>
		<title><![CDATA[Valeant?s Pain Drug Disappoints]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F158215-valeants-pain-drug-disappoints%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Yesterday, Valeant Pharmaceuticals International VRX announced the failure of its drug candidate, retigabine, in a mid-stage study. The trial evaluated retigabine for pain associated with postherpetic neuralgia PHN, which is common in shingles. The company&#8217;s shares closed down 8.5% at $ 24.85. Retigabine was tested in...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 25 Aug 2009 11:31:02 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html"><![CDATA[Valeant Pharmaceuticals International]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
		<category domain="tickers">VRX</category>
	</item>
	<item>
		<title><![CDATA[Valeant Pharmaceuticals International Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-295671.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. Operator Instructions Our first question comes from the line of Gregg Gilbert of Banc of America Merrill Lynch. Your line is open. Gregg Gilbert - BAS-ML Thanks, good morning. First of all Peter, what's the biggest change in guidance? Is it lower SG&A and R&D...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 05 May 2009 14:25:36 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/service.html"><![CDATA[Service]]></category>
		<category domain="http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html"><![CDATA[Valeant Pharmaceuticals International]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
		<category domain="tickers">VRX</category>
	</item>
	<item>
		<title><![CDATA[Valeant Pharmaceuticals International Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-272572.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Our first question comes from Gregg Gilbert with Bank of America and Merrill Lynch. Your line is open. Gregg Gilbert - Bank of America-Merrill Lynch Thank you. Good morning guys. Peter, so that we can focus on your operating metrics more clearly, can you walk...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 24 Feb 2009 12:10:35 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bank.html"><![CDATA[Bank]]></category>
		<category domain="http://resources.bnet.com/topic/alliance.html"><![CDATA[Alliance]]></category>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[Collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/r%2526d.html"><![CDATA[R&D]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html"><![CDATA[Valeant Pharmaceuticals International]]></category>
		<category domain="http://resources.bnet.com/topic/retigabine.html"><![CDATA[Retigabine]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
		<category domain="tickers">VRX</category>
	</item>
	<item>
		<title><![CDATA[Valeant Pharmaceuticals International Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-247000.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  (Operator instructions.) Our first question comes from Michael Tong of Wachovia; your line is open. Michael Tong - Wachovia Capital  Hi, good morning.  Just a more philosophical question if you could, Mike.  I have heard a lot of companies talk about preserving...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 06 Nov 2008 14:58:10 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[Acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/wachovia+corp..html"><![CDATA[Wachovia Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/brean+murray+co..html"><![CDATA[Brean Murray Co.]]></category>
		<category domain="http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html"><![CDATA[Valeant Pharmaceuticals International]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[Acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/wachovia+corp..html"><![CDATA[Wachovia Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/brean+murray+co..html"><![CDATA[Brean Murray Co.]]></category>
		<category domain="http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html"><![CDATA[Valeant Pharmaceuticals International]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WB</category>
		<category domain="tickers">VRX,WB</category>
	</item>
	<item>
		<title><![CDATA[Valeant Pharmaceuticals International Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-224231.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Mr. Gregg Gilbert. Greg Gilbert &#8211; Merrill Lynch  Thanks. Good morning. First, a few for Peter; Peter, did I hear you correctly that your best estimate for the tax bill on the $392 &#8211;? Peter Blott  Sorry, Gregg. They cut out. Yes. I...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 11 Aug 2008 12:16:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html"><![CDATA[Valeant Pharmaceuticals International]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
		<category domain="tickers">VRX</category>
	</item>
	<item>
		<title><![CDATA[Monday Options Outlook: AMZN, MCD, EL, CRME, VRX, CCK, CNO]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F90349-monday-options-outlook-amzn-mcd-el-crme-vrx-cck-cno%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Rebecca Engmann Darst co-authored this article.  Amazon.com AMZN ?Citigroup?s forecast of better-than-expected sales of its e-book reader Kindle sent shares of Amazon.com on a 10% tear to $88.66 this morning. Option traders responded with a wave of giddy and fresh action in front-month options that are due to expire...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 11 Aug 2008 09:38:53 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://resources.bnet.com/topic/amazon.com+inc..html"><![CDATA[Amazon.com Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/crown+holdings+inc..html"><![CDATA[Crown Holdings Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/conseco+inc..html"><![CDATA[Conseco Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/estee+lauder+cos.+inc..html"><![CDATA[Estee Lauder Cos. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mcdonald%2527s+corp..html"><![CDATA[McDonald's Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html"><![CDATA[Valeant Pharmaceuticals International]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CNO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CCK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MCD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
		<category domain="tickers">AMZN,CNO,CCK,EL,MCD,VRX</category>
	</item>
	<item>
		<title><![CDATA[Stocks At or Near 52-Week Highs]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89736-stocks-at-or-near-52-week-highs%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Hickey and Walters Bespoke submit:   Below we highlight stocks in the S&P 1500 that are closest to their 52-week highs.  As shown, Covance CVD is the closest, followed by WCN, ADPT, PRXL and HBHC.  Key names on the list include AMGN, GIS, BAX, HNZ, JNJ, and QCOM.  In...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 07 Aug 2008 07:51:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://resources.bnet.com/topic/adaptec+inc..html"><![CDATA[Adaptec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/baxter+international+inc..html"><![CDATA[Baxter International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/church+%2526+dwight+co.+inc..html"><![CDATA[Church & Dwight Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/conmed+corp..html"><![CDATA[Conmed Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/compuware+corp..html"><![CDATA[Compuware Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/cryolife+inc..html"><![CDATA[CryoLife Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/covance+inc..html"><![CDATA[Covance Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/first+financial+bankshares+inc..html"><![CDATA[First Financial Bankshares Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/general+mills+inc..html"><![CDATA[General Mills Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/gentiva+health+services.html"><![CDATA[Gentiva Health Services]]></category>
		<category domain="http://resources.bnet.com/topic/haemonetics+corp..html"><![CDATA[Haemonetics Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/hancock+holding+co..html"><![CDATA[Hancock Holding Co.]]></category>
		<category domain="http://resources.bnet.com/topic/h.j.+heinz+co..html"><![CDATA[H.J. Heinz Co.]]></category>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://resources.bnet.com/topic/national+presto+industries+inc..html"><![CDATA[National Presto Industries Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/parametric+technology+corp..html"><![CDATA[Parametric Technology Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/parexel+international+corp..html"><![CDATA[PAREXEL International Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/qualcomm+inc..html"><![CDATA[Qualcomm Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/qlogic+corp..html"><![CDATA[QLogic Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/symantec+corp..html"><![CDATA[Symantec Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tetra+tech+inc..html"><![CDATA[Tetra Tech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/varian+medical+systems+inc..html"><![CDATA[Varian Medical Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/valeant+pharmaceuticals+international.html"><![CDATA[Valeant Pharmaceuticals International]]></category>
		<category domain="http://resources.bnet.com/topic/waste+connections+inc..html"><![CDATA[Waste Connections Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADPT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CHD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CPWR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CNMD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FFIN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GTIV</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HNZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HAE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HBHC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NPK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PMTC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PRXL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">QLGC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">QCOM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SYMC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TTEK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VAR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WCN</category>
		<category domain="tickers">ADPT,AMGN,BAX,CHD,CPWR,CNMD,CVD,CRY,FFIN,GIS,GTIV,HNZ,HAE,HBHC,JNJ,NPK,PMTC,PRXL,QLGC,QCOM,SYMC,TTEK,VRX,VAR,WCN</category>
	</item>
</channel>
</rss>
